Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Compare tax exposure between Dividend ETFs and taxable funds and learn practical steps to lower your annual tax bill.
28,146 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
AMD’s stock has surged this year on AI demand, trading near $480 after a 129% year-to-date rally. A 129% year-to-date...
SanDisk stock has surged this quarter, but a fresh price target flags downside risk as memory pricing cools and inves...
Autonomous ride-hailing is spawning a micro-economy: drivers paid to close Waymo doors after riders exit. The gigs pa...
A famous value investor bets against Caterpillar as the AI infrastructure trend lifts the stock. Market watchers weig...
Bitcoin’s inter-exchange flow metric flashed a golden cross, prompting talk of a multi-week rally. Analysts say the p...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
Kraken confirms the listing of Pi Network’s PI token, with trading starting March 13, 2026. The move underscores grow...
A big shift in Berkshire’s thinking could put Alphabet in the spotlight for investors. This deep dive explains what t...
Nasdaq's chief executive rose through strategy to the top by embracing risk-taking over risk management. This piece t...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...